As the new president and CEO of Genome Canada, Marc LePage finds himself back in the same office he occupied 14 years ago when he was executive VP of the then fledging research agency. This time around, LePage is at the helm of a much larger, more sophisticated organization that has been instrumental in vaulting Canada back into the rapidly evolving field of genomics and proteomics.